Culmerciclib: clinical trials recruiting now
3
Recruiting trials
4
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 3
Conditions being studied
| Condition | Trials |
|---|---|
| Breast Cancer · Culmerciclib for Breast Cancer | 3 |
| HER2+ Advanced Breast Cancer | 1 |
| HR+/HER2- Early Breast Cancer | 1 |
| Metastastic Breast Cancer | 1 |
Recruiting trials involving Culmerciclib
- A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.
- Culmerciclib in HR+/HER2+ Advanced Breast Cancer
- Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer
Common questions
How many recruiting trials involve Culmerciclib?
3 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.